Women’s experiences and preferences regarding breast imaging after completing breast cancer treatment by Brandzel S, Rosenberg DE, Johnson D, Bush M, Kerlikowske K, Onega T, Henderson L, Nekhlyudov L, DeMartini W, Wernli KJ

“…Breast imaging after cancer treatment is an emotionally charged experience, an important part of survivorship care, and a topic about which limited patient information exists. …”
Get full text

β-Carboline-α-aminophosphonate Derivative: A Promising Antitumor Agent for Breast Cancer Treatment by Caroline Pinto Zani, Aline Pinto Zani, Cristiane Melissa Thomazini, Karina Miyuki Retamiro, Aline Rufino de Oliveira, Débora Laís Gonçalves, Maria Helena Sarragiotto, Francielle Pelegrin Garcia, Sueli de Oliveira Silva, Celso Vataru Nakamura, Tania Ueda-Nakamura

Get full text

Dual antineoplastic and photodynamic effects of methanolic extract of Tecoma stans yellow flowers for cancer treatment by Asmaa Y Khattab, Nagwa E Awad, Doaa Abdel Fadeel, Maha Fadel

“…Various parts of T. stans have been used in different biological applications, especially in cancer treatment. Photodynamic therapy (PDT) is a promising modality for cancer treatment that depends on the interaction between a photosensitizer, light, and oxygen. …”
Get full text

The reproductive function of patients with prior atypical endometrial hyperplasia and endometrial cancer treatment: cohort study by Lana G. Dzhanashvili, Nelly A. Khachatryan, Tat'iana A. Nazarenko, Al'mina M. Biriukova, Irina E. Dmitrieva

Get full text

Combinatorial Inhibition of Cell Surface Receptors Using Dual Aptamer-Functionalized Nanoconstructs for Cancer Treatment by Hyojin Lee, Tae Hee Kim, Daechan Park, Mihue Jang, Justin J. Chung, Soo Hyun Kim, Sang-Heon Kim, Kwan Hyi Lee, Youngmee Jung, Seung Ja Oh

Get full text

Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatment by Yuhao Wei, Yuhao Wei, Zhen Zhao, Zhen Zhao, Xuelei Ma

Subjects: Get full text

Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial by de Wit G Ardine, van Breda Eric, Gijsen Brigitte CM, Koppejan-Rensenbrink Ria AG, May Anne M, Velthuis Miranda J, Schröder Carin D, Monninkhof Evelyn M, Lindeman Eline, van der Wall Elsken, Peeters Petra HM

“…</p> <p>Methods/Design</p> <p>The Physical Activity during Cancer Treatment study is a multicentre randomised controlled trial in 150 breast and 150 colon cancer patients undergoing cancer treatment. …”
Get full text

Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment by Ni Made Pitri Susanti, Daryono Hadi Tjahjono

“…This development starts from non-selective CDK inhibitors to selective CDK4/CDK6 inhibitors, and these have been applied in clinical cancer treatment. However, these inhibitors currently require further development for various hematologic malignancies and solid tumors, based on the results demonstrated. …”
Get full text

Transanal total mesorectal excision (TaTME) in rectal cancer treatment within an expert center by Jacek Piątkowski, Mateusz Jagielski, Jacek Szeliga, Mariusz Nowak, Marek Jackowski

Get full text

Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: A comprehensive review with future perspectives by Ruolei Wang, Chunyan Wang, Lianheng Lu, Fuwen Yuan, Feng He

Get full text

Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows by Marina Elena Cazzaniga, Serena Capici, Nicoletta Cordani, Viola Cogliati, Francesca Fulvia Pepe, Francesca Riva, Maria Grazia Cerrito

Get full text

A Systematic Review of Molecular Pathway Analysis of Drugs for Potential Use in Liver Cancer Treatment by Ruchi Jakhmola Mani, Mridul Anand, Kritie Agarwal, Avi Tiwari, Qazi Amanur Rahman Hashmi, Tumul Vikram Singh, Potshangbam Nongdam, Deepshikha Pande Katare, Angamba Meetei Potshangabam

Get full text

Research Perspective: Potential Role of Nitazoxanide in Ovarian Cancer Treatment. Old Drug, New Purpose? by Jessie Ehrisman, Nicola Di Santo

Get full text

Targeting Mitochondrial DNA Transcription by POLRMT Inhibition or Depletion as a Potential Strategy for Cancer Treatment by Sabrina C. D. Daglish, Emily M. J. Fennell, Lee M. Graves

Get full text

Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment by Robert Csaba Kiss, Fen Xia, Scarlett Acklin

“…Platinum-based chemotherapies, such as cisplatin, play a large role in cancer treatment. The development of resistance and treatment toxicity creates substantial barriers to disease control, yet. …”
Get full text

Understanding Inflammasomes and PD-1/PD-L1 Crosstalk to Improve Cancer Treatment Efficiency by Anaïs Perrichet, François Ghiringhelli, Cédric Rébé

“…In this review, we provide an overview of the crosstalk between inflammasomes and programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) that might explain how these two pathways are mutually dependent, and perhaps why targeting only one of them leads to inefficiency of cancer treatment in some patients.…”
Get full text

Physical Comorbidities and Their Relationship with Cancer Treatment and Its Outcomes in Older Adult Populations: Systematic Review by Mathew George, Alexandra Smith, Sabe Sabesan, Geetha Ranmuthugala

Get full text

Developing Cardio-Oncology Programs in the New Era: Beyond Ventricular Dysfunction Due to Cancer Treatments by Alexandra Pons-Riverola, Herminio Morillas, Javier Berdejo, Sonia Pernas, Helena Pomares, Leyre Asiain, Alberto Garay, Adela Fernandez-Ortega, Ana Carla Oliveira, Evelyn Martínez, Santiago Jiménez-Marrero, Elena Pina, Eduard Fort, Raúl Ramos, Lídia Alcoberro, Encarnación Hidalgo, Maite Antonio-Rebollo, Laia Alcober, Cristina Enjuanes Grau, Josep Comín-Colet, Pedro Moliner

Get full text

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment by Eline A. M. Ruigrok, Nicole S. Verkaik, Erik de Blois, Corrina de Ridder, Debra Stuurman, Stefan J. Roobol, Dik C. Van Gent, Marion de Jong, Wytske M. Van Weerden, Julie Nonnekens

Get full text

Treating sex and gender differences as a continuous variable can improve precision cancer treatments by Wei Yang, Joshua B. Rubin

“…Conclusions Cancer type, patient sex and gender, and TI value provides a novel and patient- specific mechanistic identifier that can be used for realistic sex and gender-adaptations of precision cancer treatment planning.…”
Get full text